Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.

Bernard JB, Munoz C, Harper J, Muriello M, Rico E, Baldwin D.

J Hosp Med. 2011 May;6(5):279-84. doi: 10.1002/jhm.866.

PMID:
21661100
2.

Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.

Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, Munoz C, Newton C, Peng L, Baldwin D.

J Clin Endocrinol Metab. 2009 Feb;94(2):564-9. doi: 10.1210/jc.2008-1441. Epub 2008 Nov 18.

3.

Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections.

Cemeroglu AP, Kleis L, Wood A, Parkes C, Wood MA, Davis AT.

Endocr Pract. 2013 Jul-Aug;19(4):614-9. doi: 10.4158/EP12399.OR.

PMID:
23425652
4.
6.

Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.

Herrera KM, Rosenn BM, Foroutan J, Bimson BE, Al Ibraheemi Z, Moshier EL, Brustman LE.

Am J Obstet Gynecol. 2015 Sep;213(3):426.e1-7. doi: 10.1016/j.ajog.2015.06.010. Epub 2015 Jun 9.

PMID:
26070699
7.

COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES.

Galindo RJ, Davis GM, Fayfman M, Reyes-Umpierrez D, Alfa D, Peng L, Tamler R, Pasquel FJ, Umpierrez GE.

Endocr Pract. 2017 Sep;23(9):1059-1066. doi: 10.4158/EP171804.OR. Epub 2017 Jul 6.

PMID:
28683239
9.

Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study.

Dieuzeide G, Chuang LM, Almaghamsi A, Zilov A, Chen JW, Lavalle-González FJ.

Prim Care Diabetes. 2014 Jul;8(2):111-7. doi: 10.1016/j.pcd.2013.07.005. Epub 2013 Aug 14.

PMID:
23953707
10.

A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.

Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, Emanuele MA, Glossop V, Smallwood K, Molitch M.

Diabetes Care. 2012 Oct;35(10):1970-4. Epub 2012 Jun 14.

11.

Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy.

Gosmanov AR, Goorha S, Stelts S, Peng L, Umpierrez GE.

Endocr Pract. 2013 Mar-Apr;19(2):231-5. doi: 10.4158/EP12256.OR.

PMID:
23337144
12.

Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.

Smiley D, Umpierrez GE, Hermayer K, Newton C, Jacobs S, Olson DE, Khan A, Rizzo M, Peng L, Reyes D, Cardona S, Fonseca V.

J Diabetes Complications. 2013 Nov-Dec;27(6):637-41. doi: 10.1016/j.jdiacomp.2013.05.007. Epub 2013 Aug 1.

13.

Comparison of insulin aspart vs. regular human insulin with or without insulin detemir concerning adipozytokines and metabolic effects in patients with type 2 diabetes mellitus.

Herrmann BL, Kasser C, Keuthage W, Huptas M, Dette H, Klute A.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):210-3. doi: 10.1055/s-0033-1334905. Epub 2013 Mar 19.

PMID:
23512415
14.

Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.

Lecomte P, Foubert L, Coddens J, Dewulf B, Nobels F, Casselman F, Cammu G.

J Cardiothorac Vasc Anesth. 2011 Dec;25(6):937-42. doi: 10.1053/j.jvca.2011.03.173. Epub 2011 Jun 2.

PMID:
21640613
15.

Synergy to reduce emergency department visits for uncontrolled hyperglycemia.

Magee MF, Nassar CM, Copeland J, Fokar A, Sharretts JM, Dubin JS, Smith MS.

Diabetes Educ. 2013 May-Jun;39(3):354-64. doi: 10.1177/0145721713484593. Epub 2013 Apr 22.

PMID:
23610182
16.

Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A₁chieve study.

Malek R, Arbouche Z, Bachaoui M, Zinai S, Dahaoui A, Senoussaoui S, Salah-Mansour A.

Diabetes Res Clin Pract. 2013 Aug;101 Suppl 1:S45-9. doi: 10.1016/S0168-8227(13)70018-4.

PMID:
23958572
17.

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.

Meneghini L, Kesavadev J, Demissie M, Nazeri A, Hollander P.

Diabetes Obes Metab. 2013 Aug;15(8):729-36. doi: 10.1111/dom.12083. Epub 2013 Mar 13.

PMID:
23421331
18.

Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.

Oghazian MB, Javadi MR, Radfar M, Torkamandi H, Sadeghi M, Hayatshahi A, Gholami K.

Pharmacotherapy. 2015 Feb;35(2):148-57. doi: 10.1002/phar.1546.

PMID:
25689245
19.

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R.

Diabetes Care. 2007 Sep;30(9):2181-6. Epub 2007 May 18.

PMID:
17513708

Supplemental Content

Support Center